Fragasso Group Inc. Charles River Laboratories International, Inc. Transaction History
Fragasso Group Inc.
- $1.21 Billion
- Q2 2025
A detailed history of Fragasso Group Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fragasso Group Inc. holds 2,801 shares of CRL stock, worth $442,670. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,801
Previous 4,941
43.31%
Holding current value
$442,670
Previous $743,000
42.93%
% of portfolio
0.03%
Previous 0.07%
Shares
26 transactions
Others Institutions Holding CRL
# of Institutions
642Shares Held
54.7MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$965 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$804 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$677 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$378 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$308 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.04B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...